Scailyte appoints Tim Foley as Chief Business Officer, Jean-Pierre Rosat as Executive Chair, and Darrin Crisitello as member of the BoD.
Continue readingScailyte Strengthens Its Leadership
Scailyte Announces Virginia Savova, PhD as a Strategic and Scientific Advisor
Scailyte Announces Virginia Savova, PhD as a Strategic and Scientific Advisor. Dr. Savova brings strong expertise in computational biology, immunology, and cancer research, with a track record of high-profile publications.
Continue readingScailyte at BIO International Convention 2024
We are thrilled to attend the Bio International Convention 2024 in San Diego on June 3-6 where business and breakthroughs converge.
Continue readingInside Scailyte – Episode 10: Meet Dennis Göhlsdorf
In our latest episode of “Inside Scailyte,” we’re excited to introduce you to Dennis Göhlsdorf, our Machine Learning Engineer and co-founder at Scailyte. Dennis is at the forefront of our innovative AI-driven solutions, leveraging his expertise to drive groundbreaking advancements in single-cell omics.
Continue readingPrecision Med TRI-CON 2024
Join us for our presentation on “Enabling Precision Medicine by Combining Single-Cell Multi-Omics Data and Artificial Intelligence” in the Single-Cell Multiomics track on Thursday, March 28 at 9:35, delivered by our Senior Data Scientist, Shaoline Sheppard.
Continue readingInside Scailyte – Episode 9: Meet Shaoline Sheppard
In the latest episode of “Inside Scailyte,” we’re thrilled to introduce you to Shaoline Sheppard, our talented Senior Data Scientist. Shaoline plays a pivotal role in analyzing and interpreting data to drive insights and innovation at Scailyte.
Continue readingNextGen Omics US 2024
Scailyte is headed to NextGen Omics US 2024 in Boston, MA on March 21-22. Join us as we showcase our cutting-edge innovations in single-cell RNAseq data analysis, featuring a presentation on “Clinically Relevant Translation Of Single-Cell RNAseq Data Analysis Using ScaiVision” by our Senior Data Scientist, Julian Spagnuolo, on Wednesday, March 21 at 12:10.
Continue readingAI-driven single-cell data analysis identifies a cell signature predictive of neurotoxicity and clinical response in CAR-T cell therapy of DLBCL
In our latest white paper, “AI-driven single-cell data analysis identifies a cell signature predictive of neurotoxicity and clinical response in CAR-T cell therapy of DLBCL”, we delve deep into the transformative impact of ScaiVision, Scailyte’s pioneering platform, on the realm of CAR-T cell therapy for Diffuse Large B-Cell Lymphoma (DLBCL).
Continue readingInside Scailyte – Episode 8: Meet Sajid Maqbool
Meet Sajid Maqbool, our Information Technology Engineer at Scailyte AG. In our latest episode of “Inside Scailyte,” Sajid shares his journey, insights, and passion for driving innovation through technology.
Continue readingInside Scailyte – Episode 7: Meet Anna Dimitrova
Meet Anna Dimitrova, our Chief Financial Officer at Scailyte AG. In our latest episode of “Inside Scailyte,” Anna shares her journey, insights, and vision for our company.
Continue reading